RSV can not only reduce the levels of NF-κB and JAK-STAT, but also reduce the levels of IFN-γ, TNF-α, IL-17, and other cytokines, so RSV may have the potential to treat ILD, especially auto-immune-related ILD. This evidence concerns the gene IFNG and interstitial lung disease.